Overview


According to FutureWise analysis the market for anatomic pathology in 2023 is US$ 40.35 billion, and is expected to reach US$ 70.48 billion by 2031 at a CAGR of 7.20%.

Anatomic Pathology, also known as anatomical pathology or surgical pathology, is a specialized branch of medicine and laboratory science that deals with the examination and diagnosis of disease through the analysis of tissue specimens and bodily fluids obtained from surgical procedures, biopsies, autopsies, and other medical interventions. It plays a critical role in understanding the underlying causes of diseases, determining their extent and severity, and guiding treatment decisions.

The primary focus of anatomic pathology is the thorough microscopic examination of cells, tissues, and organs to identify abnormal changes, structural alterations, and cellular abnormalities indicative of diseases such as cancer, infections, autoimmune disorders, and genetic abnormalities. This field involves highly trained medical professionals known as pathologists, who are experts in interpreting the subtle variations in tissue structure and cellular morphology that can provide essential insights into the nature of diseases. The process of anatomic pathology involves various steps, beginning with the collection of patient specimens during surgical procedures or post-mortem examinations. These specimens are then carefully prepared, processed, and embedded in paraffin wax or other suitable materials to facilitate thin slicing, followed by staining techniques that enhance cellular features and highlight specific elements of interest. The stained tissue sections are then examined under a microscope, and pathologists meticulously analyze the cellular components and tissue architecture to arrive at accurate diagnoses.

FutureWise Market Research has published a report that provides an insightful analysis of Anatomic Pathology Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Anatomic Pathology Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • F. Hoffmann-La Roche Ltd. 
  • Danaher Corporation 
  • PHP Holdings Corporation 
  • Hologic, Inc. 
  • Agilent Technologies 
  • Becton, Dickinson and Company 
  • Sakura Finetek 
  • Merck KGaA 
  • Bio SB 
  • Diapath S.p.A. 
  • BioGenex Laboratories 

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Anatomic Pathology Market:

  • Roche revealed the Digital Pathology Open Environment in September 2021. This innovative workflow facilitates the exchange of images among researchers and medical practitioners, enhancing the quality of analysis. Notably, the platform seamlessly integrates with whole slide imaging technology. Consequently, the market benefits from the continual strategic initiatives embraced by major stakeholders, which serve to not only drive growth but also fortify their prominent positions within the industry.

The anatomic pathology market is experiencing robust growth driven by a confluence of factors. The expanding focus on personalized medicine and the rising incidence of cancer and chronic disorders are substantial drivers of this market trend. Additionally, the increasing reliance on pathology procedures and tests anchored in biomarkers to elucidate tumorigenesis and common malignancies is propelling the market forward. These clinically significant biomarkers not only aid in diagnostic test development but also serve as valuable indicators for therapeutic drug creation. The incorporation of biomarkers into pathology practices is gaining traction, assuming dual roles as diagnostic and prognostic markers. The utilization of advanced pathology systems, including digital microscopes, gross imaging, and staining systems, is set to significantly elevate anatomic pathological practices. Digital imaging solutions confer heightened accuracy and specificity advantages over conventional techniques, thus catalyzing the adoption of anatomic pathology services. Strategic initiatives by key industry players to advance pathology devices are another key driver. An illustrative instance is the strategic collaboration between Leica Biosystems and AI-based company Paige in April 2021, aimed at the development of computational pathology systems. This expansion of digital pathology portfolios is paralleled by collaborations such as Quest Diagnostics' partnership with Paige in May 2021 to innovate AI-driven cancer pathology products.

However, the market growth trajectory is not without challenges. A major hindrance is the variable error rates, ranging from the pre-analytic to the post-analytic phases of laboratory medicine workflows. These errors arise from patient or specimen misidentification, contamination, and collection issues. Notably, larger laboratories handling significant specimen volumes face higher discrepancies, impacting overall accuracy.

By Product and Service

  • Services
    • Histopathology
    • Cytopathology
  • Instruments
    • Slide Staining Systems
    • Tissue Processing Systems
    • Cell Processors
    • Microtomes
    • Embedded Systems
    • Coverslippers
    • Other Instruments (Slide Labelers, Grossing Stations, and Paraffin Dispensers)
  • Consumables
    • Antibodies
      • Primary Antibodies
      • Secondary Antibodies
    • Kits and Reagents
      • Stains and Solvents
      • Fixatives
      • Other Kits and Reagents (Blocking Sera, Chromogenic Substrates, Stabilizers, and Diluents)
    • Probes
    • Other Consumables (Microtome Blades, Slides, Coverslips, and Cassettes)

By Application

  • Disease Diagnosis
  • Cancer
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancer
    • Prostate Cancer
    • Other Cancers (Includes Cancers of the Bone, Thyroid, Cervix, Skin, Lymphoma, Gallbladder Carcinoma, Renal Cell Carcinoma, and Pleomorphic Sarcoma)
  • Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
  • Medical Research

By End-User

  • Hospital Laboratories
  • Clinical Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2021, the anatomic pathology market in North America held a prominent position, capturing the largest portion of revenue. This trend is projected to persist throughout the forecast period. The region's leadership is attributed to several factors, including the presence of established industry participants, the increasing adoption of advanced digital pathology services featuring sophisticated imaging tools, a growing emphasis on routine health screenings among the population, and supportive government policies concerning reimbursement. The concerted efforts of key market players to retain and expand their market shares have propelled the United States to a commanding stance within the industry. A noteworthy example is Agilent Technologies, which, in September 2021, unveiled a strategic partnership with Visiopharm to globally extend the reach of its artificial intelligence (AI)-driven precision pathology software. Collaborations of this nature are expected to significantly contribute to the overall growth trajectory of the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anatomic Pathology Market By Product and Service, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anatomic Pathology Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anatomic Pathology Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anatomic Pathology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anatomic Pathology Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Services
         1.1. Histopathology
         1.2. Cytopathology
        2. Instruments
         2.1. Slide Staining Systems
         2.2. Tissue Processing Systems
         2.3. Cell Processors
         2.4. Microtomes
         2.5. Embedded Systems
         2.6. Coverslippers
         2.7. Other Instruments (Slide Labelers, Grossing Stations, and Paraffin Dispensers)
        3. Consumables
         3.1. Antibodies
          3.1.1. Primary Antibodies
          3.1.2. Secondary Antibodies
         3.2. Kits and Reagents
          3.2.1. Stains and Solvents
          3.2.2. Fixatives
          3.2.3. Other Kits and Reagents (Blocking Sera, Chromogenic Substrates, Stabilizers, and Diluents)
         3.3. Probes
         3.4. Other Consumables (Microtome Blades, Slides, Coverslips, and Cassettes)

  • 8.   Anatomic Pathology Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Disease Diagnosis
        2. Cancer
         2.1. Breast Cancer
         2.2. Lung Cancer
         2.3. Gastrointestinal Cancer
         2.4. Prostate Cancer
         2.5. Other Cancers (Includes Cancers of the Bone, Thyroid, Cervix, Skin, Lymphoma, Gallbladder Carcinoma, Renal Cell Carcinoma, and Pleomorphic Sarcoma)
        3. Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
        4. Medical Research

  • 9.   Anatomic Pathology Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Laboratories
        2. Clinical Laboratories
        3. Other End Users

  • 10.   North America Anatomic Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anatomic Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anatomic Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anatomic Pathology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. F. Hoffmann-La Roche Ltd. 
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Danaher Corporation 
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. PHP Holdings Corporation 
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hologic, Inc. 
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Agilent Technologies 
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Becton, Dickinson and Company 
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Sakura Finetek 
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Merck KGaA 
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bio SB 
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Diapath S.p.A.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. BioGenex Laboratories 
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients